The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel–Lindau Disease: A Retrospective Study of 32 Patients

Background: Von Hippel-Lindau (VHL) disease is an autosomal-dominant hereditary cancer syndrome. Currently, studies on tyrosine kinase inhibitor (TKI) therapy for VHL disease are scarce. In this study, we retrospectively evaluated the efficacy and safety of four TKIs in patients with VHL disease. Me...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Oncol
Egile Nagusiak: Ma, Kaifang, Hong, Baoan, Zhou, Jingcheng, Gong, Yanqing, Wang, Jiangyi, Liu, Shengjie, Peng, Xiang, Zhou, Bowen, Zhang, Jiufeng, Xie, Haibiao, Zhang, Kenan, Li, Lei, Cai, Desheng, Wang, Zixin, Cai, Lin, Gong, Kan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2019
Gaiak:
Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6839035/
https://ncbi.nlm.nih.gov/pubmed/31737565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01122
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak